scholarly article | Q13442814 |
P50 | author | François Taddei | Q3085877 |
Isabelle Sermet-Gaudelus | Q114289835 | ||
P2093 | author name string | Kathleen McInnerney | |
Michael J Franklin | |||
Scott R Miller | |||
Agnes Ferroni | |||
Frank Rosenzweig | |||
Evgueny Kroll | |||
Ashley E Warren | |||
Kami Chiotti | |||
Carla M Boulianne-Larsen | |||
Christine B Chandler | |||
P2860 | cites work | Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen | Q22122393 |
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice | Q24286950 | ||
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients | Q24551181 | ||
Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes | Q24625992 | ||
Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients | Q24658094 | ||
Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa | Q24676453 | ||
Crystal structure of MexZ, a key repressor responsible for antibiotic resistance in Pseudomonas aeruginosa | Q27663899 | ||
DnaSP, DNA polymorphism analyses by the coalescent and other methods | Q27860965 | ||
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance | Q28185783 | ||
The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin | Q29346807 | ||
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing | Q29614699 | ||
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa | Q29615302 | ||
Statistical properties of the number of recombination events in the history of a sample of DNA sequences | Q29617408 | ||
Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa | Q31869621 | ||
Extensive genomic plasticity in Pseudomonas aeruginosa revealed by identification and distribution studies of novel genes among clinical isolates | Q33254871 | ||
Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections | Q33379091 | ||
Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways | Q33410973 | ||
Role of mutation in Pseudomonas aeruginosa biofilm development. | Q33482815 | ||
Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway | Q33523793 | ||
Interplay between pleiotropy and secondary selection determines rise and fall of mutators in stress response | Q33543179 | ||
Genetic variation: molecular mechanisms and impact on microbial evolution | Q33820587 | ||
Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients | Q33963695 | ||
Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist | Q34019954 | ||
Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. | Q34128914 | ||
Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. | Q34232085 | ||
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis | Q34588476 | ||
Selecting the best-fit model of nucleotide substitution. | Q52036759 | ||
Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. | Q53852065 | ||
Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing. | Q53857649 | ||
Diminishing Returns from Mutation Supply Rate in Asexual Populations | Q56920120 | ||
Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats | Q59334888 | ||
Infection With Transmissible Strains of Pseudomonas aeruginosa and Clinical Outcomes in Adults With Cystic Fibrosis | Q59465404 | ||
The effect of linkage on limits to artificial selection | Q72951099 | ||
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis | Q73335181 | ||
Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp--a molecular-epidemiological study | Q73885699 | ||
Iron, Pseudomonas aeruginosa and cystic fibrosis | Q76393012 | ||
A comparative evaluation of five typing techniques for determining the diversity of fluorescent pseudomonads | Q77908415 | ||
Clonal interference is alleviated by high mutation rates in large populations | Q80018606 | ||
Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis | Q84219534 | ||
Role of Horizontal Gene Transfer in the Evolution of Pseudomonas aeruginosa Virulence | Q84441866 | ||
Hypermutability and compensatory adaptation in antibiotic-resistant bacteria | Q84562380 | ||
The evolution of mutator genes in bacterial populations: the roles of environmental change and timing. | Q34617981 | ||
The fate of microbial mutators | Q34623647 | ||
Social cheating in Pseudomonas aeruginosa quorum sensing | Q34693898 | ||
Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections | Q34693974 | ||
Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa | Q35168460 | ||
Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients | Q35784162 | ||
Population structure of Pseudomonas aeruginosa | Q35808921 | ||
Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation | Q35979967 | ||
Limits to adaptation in asexual populations | Q36201707 | ||
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation | Q36295397 | ||
Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa | Q36933558 | ||
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains | Q37103851 | ||
Cooperation and virulence of clinical Pseudomonas aeruginosa populations | Q37158959 | ||
Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis | Q37597434 | ||
Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment | Q37703045 | ||
Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy | Q37788421 | ||
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance | Q37794342 | ||
Sequence diversity of Pseudomonas aeruginosa: impact on population structure and genome evolution | Q39499711 | ||
Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function | Q39504806 | ||
Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa | Q39705951 | ||
A major Pseudomonas aeruginosa clone common to patients and aquatic habitats | Q39915020 | ||
Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa. | Q40007019 | ||
Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition | Q40170508 | ||
Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. | Q40188725 | ||
Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections | Q40410503 | ||
Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. | Q40625683 | ||
Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation | Q41366386 | ||
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa | Q42704128 | ||
Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli | Q42705384 | ||
Class 1 integrons in Pseudomonas aeruginosa isolates from clinical settings in Amazon region, Brazil | Q43169107 | ||
Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants | Q43216787 | ||
Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa | Q43675781 | ||
Large chromosomal inversions occur in Pseudomonas aeruginosa clone C strains isolated from cystic fibrosis patients | Q43849615 | ||
ESTIMATING F-STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE. | Q44872734 | ||
The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa | Q45166367 | ||
Submucosal gland dysfunction as a primary defect in cystic fibrosis | Q45185643 | ||
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. | Q46002328 | ||
Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans | Q46626931 | ||
Monitoring genome evolution ex vivo: reversible chromosomal integration of a 106 kb plasmid at two tRNA(Lys) gene loci in sequential Pseudomonas aeruginosa airway isolates. | Q47824292 | ||
The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants | Q50192890 | ||
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. | Q50561588 | ||
Clinical outcome for cystic fibrosis patients infected with transmissible pseudomonas aeruginosa: an 8-year prospective study. | Q51140673 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Pseudomonas aeruginosa | Q31856 |
cystic fibrosis | Q178194 | ||
P304 | page(s) | 4802-4818 | |
P577 | publication date | 2011-09-19 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections | |
P478 | volume | 79 |
Q37280419 | A novel multiplex PCR for detection of Pseudomonas aeruginosa: A major cause of wound infections |
Q34948367 | Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. |
Q36213685 | Cystic fibrosis lung environment and Pseudomonas aeruginosa infection. |
Q26768691 | Experimental evolution in biofilm populations. |
Q30278439 | Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains |
Q35867693 | Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hypoxia-induced stress response in the metabolically active population |
Q38807634 | Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. |
Q36075893 | Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins. |
Q35607468 | Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study |
Q28492531 | Rapid evolution of culture-impaired bacteria during adaptation to biofilm growth |
Q34906024 | Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection |
Q40304380 | Resuscitation of Pseudomonas aeruginosa from dormancy requires hibernation promoting factor (PA4463) for ribosome preservation |
Q92893172 | Streamlined preparation of genomic DNA in agarose plugs for pulsed-field gel electrophoresis |
Q47615734 | The effect of loss of O-antigen ligase on phagocytic susceptibility of motile and non-motile Pseudomonas aeruginosa |
Q34922676 | The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility |
Q37287175 | Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung |
Q91152132 | Variation of Burkholderia cenocepacia cell wall morphology and mechanical properties during cystic fibrosis lung infection, assessed by atomic force microscopy |
Search more.